FENNEC PHARMACEUTICALS INC. Annual Nonoperating Income (Expense) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
  • Fennec Pharmaceuticals Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was -$514K, a 33.9% increase year-over-year.
  • Fennec Pharmaceuticals Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was -$3.13M, a 26.8% decline year-over-year.
  • Fennec Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2023 was -$3.27M, a 191% decline from 2022.
  • Fennec Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2022 was -$1.13M, a 815% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Nonoperating Income (Expense) for 2021 was -$123K, a 45.1% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.27M -$2.15M -191% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$1.13M -$1M -815% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$123K +$101K +45.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$224K -$458K -196% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $234K -$287K -55.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $521K +$616K Jan 1, 2018 Dec 31, 2018 10-K 2020-02-14
2017 -$95K -$177K -216% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
2016 $82K -$1.15M -93.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
2015 $1.23M +$530K +75.6% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-29
2014 $701K -$3.08M -81.4% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 $3.78M +$5.32M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 -$1.54M -$9.67M -119% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 $8.12M +$11.3M Jan 1, 2011 Dec 31, 2011 10-K 2013-04-01
2010 -$3.22M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.